e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Louise J.P Persson, Marianne Aanerud, Jon A. Hardie, Roy Miodini Nilsen, Per S. Bakke, Tomas M. Eagan, Pieter S. Hiemstra
Source:
Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Louise J.P Persson, Marianne Aanerud, Jon A. Hardie, Roy Miodini Nilsen, Per S. Bakke, Tomas M. Eagan, Pieter S. Hiemstra. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006
Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013
Small airway inflammation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Stable chronic obstructive pulmonary disease-bronchial colonization and inflammatory response
Source: Eur Respir J 2001; 18: Suppl. 33, 105s
Year: 2001
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Bronchial colonization and inflammatory response in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001
Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013
Malnutrition influences exacerbations and airways bacterial colonization in COPD patients with chronic respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 540s
Year: 2003
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
Source: Eur Respir J 2002; 19: 966-975
Year: 2002
Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept